Healius Ltd (HLS)

Currency in AUD
0.460
+0.030(+6.98%)
Closed·
Advertisement
HLS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4250.460
52 wk Range
0.3001.070
Key Statistics
Bid/Ask
0.45 / 0.46
Prev. Close
0.43
Open
0.425
Day's Range
0.425-0.46
52 wk Range
0.3-1.07
Volume
2.83M
Average Volume (3m)
3.99M
1-Year Change
-45.8824%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HLS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.547
Upside
+18.99%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Healius Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

2 Buy
4 Hold
4 Sell
Ratings:
10 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.547
(+18.99% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
RBC Capital
Sell0.35-23.91%0.75Downgrade14/05/2026
Goldman Sachs
Sell0.57+23.91%0.66Maintain13/03/2026
RBC Capital
Hold0.75+63.04%0.95Maintain19/02/2026
Goldman Sachs
Sell0.66+43.48%0.77Maintain18/02/2026
Jefferies
Hold0.81+76.09%-Upgrade18/02/2026

Healius Ltd Earnings Call Summary for H2/2026

  • Healius reported FY26 revenue of AUD 1.37B (+2.1%) and EBIT of AUD 30.2M (+76.6%), driven by pricing mix and cost cuts.
  • Company recorded AUD 332M goodwill impairment and shifted to net debt of AUD 32.8M from prior year net cash position.
  • FY27 EBIT guidance of AUD 39.7M includes AUD 15M Fair Work Commission wage impact; expects positive cash flow ahead.
  • Digital transformation largely complete with 80%+ episodes on Medway platform; AI and automation tools now in production.
  • Shares fell 3.37% to $0.43 despite beat, pressured by weak GP trends, telehealth shift, and contract losses in hospital segment.
Last Updated: 19/08/2026, 02:42
Read Full Transcript

Earnings

Latest Release
18/08/2026
EPS / Forecast
-- / 7.68
Revenue / Forecast
-- / 971M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.56%
Dividend Yield
-
Industry Median 3.07%
Annualised payout
-
Paid unevenly
5-Years Growth
-
Growth Streak

Compare HLS to Peers and Sector

Metrics to compare
HLS
Peers
Sector
Relationship
P/E Ratio
−0.8x20.7x−0.4x
PEG Ratio
0.000.050.00
Price/Book
1.8x1.7x2.6x
Price / LTM Sales
0.2x1.2x3.1x
Upside (Analyst Target)
2.8%18.9%49.0%
Fair Value Upside
Unlock14.1%7.1%Unlock

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
95.12M13.10%40.42M
Other Institutional Investors
733.88M86.90%311.90M
Public Companies & Retail Investors
0.000.00%0.00
Total
829M100.00%352.32M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Tanarra Capital Australia Pty Ltd19.80%143,811,58761,120
Spheria Asset Management Pty Ltd15.03%109,143,99446,386

FAQ

What Is the Primary Health Care (Sydney: HLS) Share Price Today?

The Primary Health Care stock price today is 0.460 AUD.

What Stock Exchange Does Primary Health Care (HLS) Trade On?

Primary Health Care is listed and trades on the Sydney Stock Exchange.

What Is the Ticker (Stock Symbol) for Primary Health Care?

The stock symbol (also called a 'ticker') for Primary Health Care is "HLS."

What Is the Current Primary Health Care Market Capitalisation?

As of today, Primary Health Care (Sydney: HLS) market cap is 312.250M AUD.

What Is Primary Health Care's (HLS) Earnings Per Share (TTM)?

The Primary Health Care EPS is currently -0.563 (Trailing Twelve Months).

When Is the Next Primary Health Care Earnings Date?

Primary Health Care's next earnings report will be released on 22/10/2026.

Is HLS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Primary Health Care moving averages and other technical indicators, the daily buy/sell signal for HLS stock is Neutral.

How Many Times Has Primary Health Care Stock Split?

Primary Health Care has split 2 times. (See the HLS stock split history page for full effective split date and price information.)

How Many Employees Does Primary Health Care Have?

Primary Health Care has 6000 employees, based on their latest Companies House report.

What is the current trading status of Primary Health Care (Sydney: HLS)?

As of 03/09/2026, Primary Health Care (HLS) is trading at a share price of 0.460 AUD, with a previous close of 0.430 AUD. The stock has fluctuated within a day range of 0.425 AUD to 0.460 AUD, while its 52-week range spans from 0.300 AUD to 1.070 AUD.

What Is Primary Health Care (HLS) Price Target According to Analysts?

The average 12-month price target for Primary Health Care is 0.547 AUD, with a high estimate of 1.3 AUD and a low estimate of 0.37 AUD. 2 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Neutral. The stock has an +18.99% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.